Author: News Room
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSV: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to announce the filing of a technical report for the updated mineral resource estimate (“MRE”), reported on October 15, 2024, for its Los Reyes gold-silver project (“Los Reyes” or the “Project”) located in Sinaloa State, Mexico. The report, dated November 27, 2024, is titled “The Los Reyes Project, México Technical Report” (the “2024 Technical Report”) and reflects drilling up to July 17, 2024. The 2024 Technical Report was prepared under the supervision of Mr. John Sims,…
MINNEAPOLIS, Nov. 27, 2024 (GLOBE NEWSWIRE) — Rally House, the fastest growing officially licensed sports apparel and merchandise retailer in the nation, announces they have opened their doors to the newest Rally House location in the Twin Cities area with Rally House Maple Grove. Rally House entered the Minnesota market this year with their first location of Rally House Tamarack Village in Woodbury. Now, the company proudly operates five storefront locations throughout the state. Find Rally House in the Maple Grove Crossing shopping mall, between Five Below and Old Navy. Rally House Maple Grove brings high-quality licensed sports gear to…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Rentokil To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Rentokil between December 1, 2023 and September 10, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rentokil Initial plc (“Rentokil”…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Dentsply between December 1, 2022 and November 6 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. (“Dentsply”…
Beverly Hills, California, Nov. 27, 2024 (GLOBE NEWSWIRE) — Mission Matters announces that DJ, violinist and singer Esther Anaya has teamed up with world-renowned DJ and producer Thomas Gold to form a groundbreaking DJ duo, Anaya & Gold. The duo produced a blowout performance at the SoFi Stadium for the Los Angeles Chargers versus Cincinnati Bengals during the Sunday Night Football game, delivering an unforgettable halftime show. Their unique set featured live violin, vocals, keyboards and drums, captivating the crowd with an immersive music ensemble. “Back in March, Esther and I had just met, and in such a short time,…
Dallas, Nov. 27, 2024 (GLOBE NEWSWIRE) — The Wells Fargo Foundation has awarded $80,000 in funding to Dallas Area Habitat for Humanity to build an affordable home in southern Dallas. Dallas Habitat is one of 179 local Habitat for Humanity affiliates awarded grant funding through the 2024 Wells Fargo Builds program to increase access to affordable homes across the U.S. The grant helped volunteers from Dallas area Wells Fargo branches, Dallas Habitat, and local families build a new home in a region of Dallas that is revitalizing with new and restored homes and engaged families. It comes at a time when at least…
CHICAGO, Nov. 27, 2024 (GLOBE NEWSWIRE) — The Foundation for Sarcoidosis Research (FSR) is proud to announce the recipients of the 2024 FSR Cardiac Sarcoidosis Grant, providing $200,000 in funding to advance groundbreaking research aimed at improving the diagnosis, management, and treatment of cardiac sarcoidosis and doubling FSR’s investment from 2023. FSR has awarded two grants, each in the amount of $100,000, to Dr. Eliot Peyster, MD, MSc, Assistant Professor of Medicine at the University of Pennsylvania, and Dr. Ravi Karra, MD, MHS, Associate Professor of Medicine and Pathology at Duke University. These grants support innovative projects designed to improve…
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) — The “Europe Digital Twin Market: Focus on Application, End User, Type, Product Offering, and Country – Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering.The Europe digital twin market is projected to reach $297.5 billion by 2033 from $3.0 billion in 2023, growing at a CAGR of 58.55% during the forecast period 2023-2033 The growing use of cutting-edge technologies like the Internet of Things (IoT), artificial intelligence (AI), and big data analytics has propelled the impressive expansion of the European digital twin market. Digital twins, which produce virtual versions of real-world…
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) — The “Menopausal Hot Flashes Market by Treatment Type, Distribution Channel – Global Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.The Menopausal Hot Flashes Market grew from USD 8.24 billion in 2023 to USD 8.64 billion in 2024. It is expected to continue growing at a CAGR of 6.18%, reaching USD 12.54 billion by 2030. The market scope for products addressing this condition encompasses pharmaceuticals, hormone replacement therapies, dietary supplements, botanical/herbal treatments, and non-hormonal drugs. Market growth is fuelled by increasing awareness and acceptance of menopause as a significant health concern, encouraging innovation…
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) — The “Next Generation Cancer Diagnostics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The global market for Next Generation Cancer Diagnostics was estimated at US$16.6 Billion in 2023 and is projected to reach US$64.6 Billion by 2030, growing at a CAGR of 21.4% from 2023 to 2030. The growth in the Next Generation Cancer Diagnostics market is driven by several factors, including the increasing prevalence of cancer, which has heightened the demand for more effective screening and diagnostic tools. The shift toward personalized medicine, driven by advancements in genomics and…